FDA Inspection
Anna Jaques Hospital LaboratoryAnna Jaques Hospital Laboratory – FDA Inspection, Mar 30, 2011
Record Details
This FDA Inspection record concerns Anna Jaques Hospital Laboratory, with an inspection on March 30, 2011, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- March 30, 2011
- Product Type
- Biologics
View Company Profile
ID · c576071d-9877-4f82-8352-018185ebd8e1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 717231
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 610.41Donor Deferral
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Anna Jaques Hospital Laboratory
6| Date | Classification | Office | Project area |
|---|---|---|---|
| July 26, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 10, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 19, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 15, 2014 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 4, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Anna Jaques Hospital Laboratory
- FDA Inspection 1177226 - 2022-07-26
- FDA Inspection 1076540 - 2018-12-10
- FDA Inspection 998359 - 2017-01-19
- FDA Inspection 907802 - 2014-12-15
- FDA Inspection 780131 - 2012-05-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.